India likely to take diplomatic route to deal with US sanctions on firms

India has the option to take up the matter of sanctions on 24 companies by the US with the World Trade Organisation (WTO) or International Court of Justice (ICJ) but is is more likely to engage in direct diplomacy with Washington to address its concerns, according to a report. Th country may seek exemptions for specific sectors or companies in these bilateral talks.

“While unilateral sanctions imposed by the US are controversial under international law, the practical reality is that countries like India must navigate these sanctions carefully to protect their business interests,” the report by Global Trade Research Initiative (GTRI) said.

Also ReadVedanta swings to black with Q2 profit at Rs 5,603 crore, revenue down 3.6% YoY

India can engage diplomatically with the US and other international bodies to seek remedies, but the broader trend of extraterritorial sanctions poses a challenge to international trade law and the principle of state sovereignty, it said.

On October 30, the US State Department and the Treasury’s Office of Foreign Assets Control (OFAC) imposed sanctions on nearly 400 entities and individuals, including 19 Indian companies and two individuals, for supporting Russia’s military activities in Ukraine. Then on November 1, the US Department of Commerce (DOC) added five Indian companies to its Entity List for acquiring and redirecting US-made goods to Russia’s defence sector.

The companies that are on DOC list are Shreya Life Sciences, Soni Electronics, Solex Electronics, Asha Electronics and S M Electronics.

The official stance of India on the sanctions was that affected entities did not violate Indian laws and that it would work with domestic agencies to ensure businesses comply with export control guidelines and non-proliferation commitments.

“To prevent future sanctions, India may plan to tighten export controls, offer clearer business guidelines, and ensure strict compliance. The recent US sanctions highlight the importance for Indian businesses to follow both local and international trade regulations, especially when dealing with sensitive or dual-use goods. Companies must stay vigilant to avoid inadvertently supporting sanctioned entities or countries,” the GTRI said..

It’s crucial for businesses to have strong compliance programs and regularly check export control lists like India’s SCOMET list and US BIS regulations. Failing to comply can lead to serious consequences, including trade restrictions, frozen assets, and lost market access.

 » Read More

Related Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain